Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.000p
   
  • Closing Price Chg:
      1.00p
  • 52 Week High: 17.60
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 502.22m
  • Volume: 0
  • RiskGrade: 328

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-25 Interim n/a (1.95) (0.38)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.13 (7.25) 3.43p 3.9 n/a n/a n/a 0.0%
31-Dec-21 0.12 (8.94) (3.25)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (4.46) (1.26)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (3.42) (0.81)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (2.78) (0.60)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 3.89 n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Immupharma Market Data

Currency UK Pounds
Share Price 12.00p
Closing Price Change 1.00p
% Change 0.00 %
52 Week High 17.60
52 Week Low 1.09
Volume 0
Shares Issued 502.22m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 19-Sep-2025

Time Volume / Share Price
15:23 12,863 @ 11.60p
15:19 1,319 @ 11.90p
14:19 75,000 @ 11.55p
15:18 42,175 @ 11.85p
15:14 10,433 @ 11.55p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page